Patient Education Sheet Library
Search Results
Downloads:
Download (English)Palbociclib and Trastuzumab
The combination of palbociclib and trastuzumab is used for breast cancer.
Treatment Given by Infusion Treatment Given by Injection Treatment Taken by MouthDownloads:
Palbociclib, Trastuzumab, and Pertuzumab
The combination of palbociclib, trastuzumab, and pertuzumab is used for breast cancer.
Treatment Given by Infusion Treatment Given by Injection Treatment Taken by MouthDownloads:
Capivasertib, Abiraterone, and Prednisone
The combination of capivasertib, abiraterone, and prednisone is used for prostate cancer.
Treatment Taken by MouthDownloads:
Tafasitamab, Rituximab, and Lenalidomide
The combination of tafasitamab, rituximab, and lenalidomide (Tafa-R2) is used for follicular lymphoma (FL).
Treatment Given by Infusion Treatment Given by Injection Treatment Taken by MouthDownloads:
Obinutuzumab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
The combination of obinutuzumab and cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) is used for follicular…
Treatment Given by Infusion Treatment Taken by MouthDownloads:
Obinutuzumab and Cyclophosphamide, Vincristine, and Prednisone
This combination of obinutuzumab and cyclophosphamide, vincristine, and prednisone (CVP) is used for follicular lymphoma…
Treatment Given by Infusion Treatment Taken by MouthDownloads:
Downloads:
Cyclosporine
Cyclosporine is used for graft-versus-host disease (GVHD).
Treatment Given by Infusion Treatment Taken by MouthDownloads:
Etoposide, Doxorubicin, Cisplatin, and Mitotane
The combination of etoposide, doxorubicin, cisplatin, and mitotane (EDP-M) is used for cancer of the…
Treatment Given by Infusion Treatment Taken by MouthDownloads:
Popular Searches
PES Review Committee
The Patient Education Sheet (PES) Committee is a multidisciplinary team of oncology professionals who guide the development and review of these important resources. This committee ensures that every PES is accurate, clear, and meaningful for patients and caregivers navigating cancer treatment.
Led by NCODA and supported through collaboration with three leading professional organizations—ACCC, HOPA, and ONS—the committee combines expertise from across the oncology care spectrum. Together, they uphold best practices, promote consistency in patient education, and remain committed to improving outcomes through accessible, patient-centered information.
